Zobrazeno 1 - 10
of 1 008
pro vyhledávání: '"Luis M. Ruilope"'
Autor:
Miriam Anfaiha‐Sanchez, Aranzazu Santiago‐Hernandez, Juan Antonio Lopez, Nerea Lago‐Baameiro, Maria Pardo, Ariadna Martin‐Blazquez, Jesus Vazquez, Gema Ruiz‐Hurtado, Maria G. Barderas, Julian Segura, Luis M. Ruilope, Marta Martin‐Lorenzo, Gloria Alvarez‐Llamas
Publikováno v:
Journal of Extracellular Biology, Vol 3, Iss 9, Pp n/a-n/a (2024)
Abstract Background Current definition of chronic kidney disease (CKD) identifies only advanced stages, but effective management demands early detection. Urinary albumin‐to‐creatinine ratio (ACR) 30 mg/g is a cut‐off point for CKD clinical diag
Externí odkaz:
https://doaj.org/article/fd75a9bccf884ac09ddf0ac640f313df
Autor:
Antonio Rodríguez-Miguel, Beatriz Fernández-Fernández, Alberto Ortiz, Miguel Gil, Sara Rodríguez-Martín, Gema Ruiz-Hurtado, Encarnación Fernández-Antón, Luis M. Ruilope, Francisco J. de Abajo
Publikováno v:
Pharmaceuticals, Vol 17, Iss 10, p 1299 (2024)
Background/Objectives: The burden of chronic kidney disease (CKD) is increasing, as is the prevalence of type 2 diabetes mellitus (T2DM). Post-hoc analyses of clinical trials support that sodium–glucose cotransporter-2 inhibitors (SGLT-2i) and gluc
Externí odkaz:
https://doaj.org/article/a4dcd3d8329a41cd8a662dd332fac1b9
Autor:
John M. Flack, Rajiv Agarwal, Stefan D. Anker, Bertram Pitt, Luis M. Ruilope, Peter Rossing, Sharon G. Adler, Linda Fried, Kenneth Jamerson, Robert Toto, Meike Brinker, Alfredo E. Farjat, Peter Kolkhof, Robert Lawatscheck, Amer Joseph, George L. Bakris
Publikováno v:
Kidney Medicine, Vol 5, Iss 12, Pp 100730- (2023)
Rationale & Objective: In FIDELITY, finerenone improved cardiorenal outcomes in patients with chronic kidney disease (CKD) and type 2 diabetes (T2D). This analysis explored the efficacy and safety of finerenone in Black patients. Study Design: Subana
Externí odkaz:
https://doaj.org/article/59115e7a11df4a8396c5090a6e79d0dd
Autor:
Sylvia E. Rosas, Luis M. Ruilope, Stefan D. Anker, Bertram Pitt, Peter Rossing, Andres Angelo Cadena Bonfanti, Ricardo Correa-Rotter, Fernando González, Carlos Francisco Jaramillo Munoz, Pablo Pergola, Guillermo E. Umpierrez, Andrea Scalise, Charlie Scott, Robert Lawatscheck, Amer Joseph, George L. Bakris
Publikováno v:
Kidney Medicine, Vol 5, Iss 10, Pp 100704- (2023)
Rationale & Objective: In FIDELITY, finerenone improved cardiorenal outcomes in patients with chronic kidney disease (CKD) and type 2 diabetes. This analysis explores the efficacy and safety of finerenone in Hispanic patients. Study Design: Post hoc
Externí odkaz:
https://doaj.org/article/38abc2dc58b54b729cd012f48348caf8
Autor:
Luis Matavelli, Gerasimos Filippatos, Stefan D. Anker, George L. Bakris, Peter Rossing, Luis M. Ruilope, Luke Roberts, Meike Brinker, Alfredo Farjat, Bertram Pitt
Publikováno v:
American Journal of Preventive Cardiology, Vol 15, Iss , Pp 100544- (2023)
Therapeutic Area: Kidney Disease Background: Left ventricular hypertrophy (LVH) is a predictor of cardiovascular (CV) disease and associated morbidity and mortality. Patients with chronic kidney disease (CKD), type 2 diabetes (T2D) have a higher prev
Externí odkaz:
https://doaj.org/article/7c3d5861874e47f58fe6ade784f013ea
Autor:
Alejandro Santos-Lozano, Alberto Torres Barrán, Pablo Fernández-Navarro, Pedro L. Valenzuela, Adrián Castillo-Garcia, Luis M. Ruilope, David Ríos Insua, José M. Ordovas, Victoria Ley, Alejandro Lucia
Publikováno v:
Journal of Sport and Health Science, Vol 10, Iss 5, Pp 604-606 (2021)
Externí odkaz:
https://doaj.org/article/50374314f8de4aec8e7ce17ebb06fd68
Publikováno v:
Frontiers in Cardiovascular Medicine, Vol 9 (2022)
Physical exercise reduces blood pressure (BP) in patients with hypertension in general but more evidence is needed specifically for a high-risk phenotype associated with intensive medication, resistant hypertension (RH). In this systematic review and
Externí odkaz:
https://doaj.org/article/4b8d4878c2424d3897b9ea4be63ac21f
Autor:
Aranzazu Santiago-Hernandez, Paula J. Martinez, Marta Martin-Lorenzo, Gema Ruiz-Hurtado, Maria G Barderas, Julian Segura, Luis M. Ruilope, Gloria Alvarez-Llamas
Publikováno v:
Nefrología, Vol 40, Iss 4, Pp 440-445 (2020)
Resumen: Antecedentes y objetivo: La albuminuria es un indicador de daño orgánico subclínico y un marcador de riesgo cardiovascular y de enfermedad renal. Un porcentaje de pacientes hipertensos desarrollan albuminuria a pesar de estar bajo supresi
Externí odkaz:
https://doaj.org/article/8048f3d2bed344e5977f50766f9e9cee
Autor:
José Alberto Navarro-García, Laura González-Lafuente, María Fernández-Velasco, Luis M. Ruilope, Gema Ruiz-Hurtado
Publikováno v:
Frontiers in Physiology, Vol 12 (2021)
Cardiorenal syndrome (CRS) is a complex disorder that refers to the category of acute or chronic kidney diseases that induce cardiovascular disease, and inversely, acute or chronic heart diseases that provoke kidney dysfunction. There is a close rela
Externí odkaz:
https://doaj.org/article/ac6da582782d4dc9a8681efa0f0a5d0f
Autor:
Florian G. Scurt, Jan Menne, Sabine Brandt, Anja Bernhardt, Peter R. Mertens, Hermann Haller, Christos Chatzikyrkou, Sadayoshi Ito, Josphe L. Izzo, Andrzeij Januszewicz, Shigerhiro Katayama, Albert Mimram, Ton J. Rabelink, Eberhard Ritz, Luis M. Ruilope, Lars C. Rump, Giancarlo Viberti, Herrman Haller
Publikováno v:
Kidney International Reports, Vol 4, Iss 10, Pp 1373-1386 (2019)
Aim: The aim of the case-control study was to investigate if serum biomarkers indicative of vascular inflammation and endothelial dysfunction can predict the development of microalbuminuria in patients with diabetes mellitus type 2. Methods: Among pa
Externí odkaz:
https://doaj.org/article/c233dfea8bc24170947f739946206627